Chlorpheniramine / Methscopolamine / Pseudoephedrine Dosage
Applies to the following strengths: 8 mg-2.5 mg-90 mg; 8 mg-2.5 mg-120 mg; varying strength; 4 mg-1.25 mg-60 mg; 8 mg-1.25 mg-60 mg; 4 mg-1.25 mg-30 mg/ 5 mL; 6 mg-2.5 mg-120 mg
Usual Adult Dose for:
Usual Pediatric Dose for:
Additional dosage information:
Usual Adult Dose for Allergic Rhinitis
Chlorpheniramine/methscopolamine/PSE 4 mg-1.25 mg-30 mg/ 5 mL oral syrup:
5 to 10 mL orally every 4 to 6 hours not to exceed 40 mL daily.
Chlorpheniramine/methscopolamine/PSE 4 mg-1.25 mg-60 mg oral tablet, extended release:
1 to 2 tablets orally every 12 hours not to exceed 2 doses daily.
Chlorpheniramine/methscopolamine/PSE 6 mg-2.5 mg-120 mg oral tablet, extended release:
1 tablet orally per day.
Usual Adult Dose for Nasal Congestion
Chlorpheniramine/methscopolamine/PSE 4 mg-1.25 mg-30 mg/ 5 mL oral syrup:
5 to 10 mL orally every 4 to 6 hours not to exceed 40 mL daily.
Chlorpheniramine/methscopolamine/PSE 4 mg-1.25 mg-60 mg oral tablet, extended release:
1 to 2 tablets orally every 12 hours not to exceed 2 doses daily.
Chlorpheniramine/methscopolamine/PSE 6 mg-2.5 mg-120 mg oral tablet, extended release:
1 tablet orally per day.
Usual Adult Dose for Sinus Symptoms
Chlorpheniramine/methscopolamine/PSE 4 mg-1.25 mg-30 mg/ 5 mL oral syrup:
5 to 10 mL orally every 4 to 6 hours not to exceed 40 mL daily.
Chlorpheniramine/methscopolamine/PSE 4 mg-1.25 mg-60 mg oral tablet, extended release:
1 to 2 tablets orally every 12 hours not to exceed 2 doses daily.
Chlorpheniramine/methscopolamine/PSE 6 mg-2.5 mg-120 mg oral tablet, extended release:
1 tablet orally per day.
Usual Pediatric Dose for Allergic Rhinitis
Chlorpheniramine/methscopolamine/PSE 4 mg-1.25 mg-30 mg/ 5 mL oral syrup:
6 to 11 years: 5 mL orally every 4 to 6 hours not to exceed 20 mL daily.
12 years or older: 5 to 10 mL orally every 4 to 6 hours not to exceed 40 mL daily.
Chlorpheniramine/methscopolamine/PSE 4 mg-1.25 mg-60 mg oral tablet, extended release:
6 to 11 years: 1 tablet orally every 12 hours not to exceed 2 doses daily.
12 years or older: 1 to 2 tablets orally every 12 hours not to exceed 2 doses daily.
Chlorpheniramine/methscopolamine/PSE 6 mg-2.5 mg-120 mg oral tablet, extended release:
12 years or older: 1 tablet orally per day.
Usual Pediatric Dose for Nasal Congestion
Chlorpheniramine/methscopolamine/PSE 4 mg-1.25 mg-30 mg/ 5 mL oral syrup:
6 to 11 years: 5 mL orally every 4 to 6 hours not to exceed 20 mL daily.
12 years or older: 5 to 10 mL orally every 4 to 6 hours not to exceed 40 mL daily.
Chlorpheniramine/methscopolamine/PSE 4 mg-1.25 mg-60 mg oral tablet, extended release:
6 to 11 years: 1 tablet orally every 12 hours not to exceed 2 doses daily.
12 years or older: 1 to 2 tablets orally every 12 hours not to exceed 2 doses daily.
Chlorpheniramine/methscopolamine/PSE 6 mg-2.5 mg-120 mg oral tablet, extended release:
12 years or older: 1 tablet orally per day.
Usual Pediatric Dose for Sinus Symptoms
Chlorpheniramine/methscopolamine/PSE 4 mg-1.25 mg-30 mg/ 5 mL oral syrup:
6 to 11 years: 5 mL orally every 4 to 6 hours not to exceed 20 mL daily.
12 years or older: 5 to 10 mL orally every 4 to 6 hours not to exceed 40 mL daily.
Chlorpheniramine/methscopolamine/PSE 4 mg-1.25 mg-60 mg oral tablet, extended release:
6 to 11 years: 1 tablet orally every 12 hours not to exceed 2 doses daily.
12 years or older: 1 to 2 tablets orally every 12 hours not to exceed 2 doses daily.
Chlorpheniramine/methscopolamine/PSE 6 mg-2.5 mg-120 mg oral tablet, extended release:
12 years or older: 1 tablet orally per day.
Renal Dose Adjustments
Data not available
Liver Dose Adjustments
Data not available
Precautions
The FDA has not approved use of over-the-counter cough and cold medications to children aged less than 2 years, and proper dosing for children in this age group has not been studied. Clinicians should be aware of the risk for serious illness or fatal overdose from administration of cough and cold medications to children aged less than 2 years. Clinicians should be certain that caregivers understand 1) the importance of administering cough and cold medications only as directed and 2) the risk for overdose if they administer additional medications that might contain the same ingredient.
Dialysis
Data not available
More about chlorpheniramine / methscopolamine / pseudoephedrine
- Check interactions
- Compare alternatives
- Reviews (4)
- Drug images
- Side effects
- Drug class: upper respiratory combinations
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
